Tekton Tekton Research Expands Leadership Team with the Addition of Russell Smith as Chief Operating Officer
RSV Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)